Author

A. Ilyichev

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Current state of monkeypox vaccine development

The global monkeypox outbreak in 2022, which affected more than 120 countries, marked the transition of this disease from an endemic condition to a global public-health threat. A decline in herd immunity following cessation of routine smallpox vaccination, together with the insufficiency of existing vaccines, underscor...

A. A. Sulgin, A. Ilyichev, M. Azaev et al. · Journal of microbiology, epi... · 0 citations

Open access Oct 2026

A two-component mRNA vaccine combining B-cell and T-cell immunogens of SARS-CoV-2 induces humoral and cellular immune responses in mice

INTRODUCTION. Despite the effectiveness of existing COVID-19 vaccines, the emergence of new SARS-CoV-2 variants necessitates the development of immunogens capable of eliciting a broad, cross-reactive immune response. A promising approach is the development of mRNA vaccines that induce both humoral and T-cell respons...

M. B. Borgoyakova, A. P. Rudometov, S. V. Sharabrin et al. · Biological Products. Prevent... · 0 citations

Open access Oct 2026

Administration of the mRNA-H5 vaccine to ferrets via jet injection provides protective immunity against the H5N1 influenza virus

INTRODUCTION. The highly pathogenic avian influenza virus subtype H5Nx is rapidly evolving and infecting various species of wild and domestic mammals, including cattle, highlighting its pandemic potential for humans. To combat the pandemic threat, it is essential to develop suitable vaccine platforms, including mRNA...

V. R. Litvinova, A. Gudymo, V. A. Yakovlev et al. · Biological Products. Prevent... · 0 citations